ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652168; 2) Community: the network communities that were significantly associated with the response to NSC 652168; 3) Molecule: the relationships between components within communities and NSC 652168; 4) MDR: the compounds that were significantly associated with the NSC 652168.

NSC Compound Enrichment Correlation
NSC 632791 Platinum, dichloro[(methylsulfinyl)phenyl-S](quinoline-N)-, (SP-4-1) 0.03888574812161 0.38810976
NSC 634784 4-Piperidinone, 1-[3-(dimethylamino)-1-oxopropyl]-3,5- bis(phenylmethylene)-, monohydrochloride 0.03888574812161 0.27787129
NSC 645323 Null 0.03888574812161 -0.032240661
NSC 648322 Incarnal 0.03888574812161 0.28622643
NSC 681644 Camptothecin Derivative 0.0388857481216103 0.043108268
NSC 683557 Camptothecin Derivative 0.0388857481216103 0.072367668
NSC 146769 Null 0.0422011701988039 0.27029076
NSC 191959 Michicarcin 0.0422011701988039 0.16313618
NSC 253995 Europate(1-), tetrakis(4,4,4-trifluoro-1-phenyl-1,3-butanedionato-O,O')-, hydrogen, compd. with pyridine 0.0422011701988039 0.099289188
NSC 293074 Null 0.0422011701988039 0.37884621
Total:105  Current:80    [First] [Prev] [Next] [Last]